Postes actifs de Kristine de Sutter
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ABLYNX | Directeur/Membre du Conseil | 01/04/2019 | - |
Historique de carrière de Kristine de Sutter
Statistiques
Internationale
| Belgique | 2 |
Opérationnelle
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
- Bourse
- Insiders
- Kristine de Sutter
- Expérience
